Results 251 to 260 of about 112,390 (279)

In silico thrombectomy trials for acute ischemic stroke

open access: yesComputer Methods and Programs in Biomedicine, 2023
In silico trials aim to speed up the introduction of new devices in clinical practice by testing device design and performance in different patient scenarios and improving patient stratification for optimizing clinical trials. In this paper, we demonstrate an in silico trial framework for thrombectomy treatment of acute ischemic stroke and apply this ...
Claire Miller   +2 more
exaly   +7 more sources

In Silico Clinical Trials: Is It Possible?

2023
Modeling and simulation (M&S), including in silico (clinical) trials, helps accelerate drug research and development and reduce costs and have coined the term "model-informed drug development (MIDD)." Data-driven, inferential approaches are now becoming increasingly complemented by emerging complex physiologically and knowledge-based disease (and drug)
Simon, Arsène   +16 more
openaire   +2 more sources

In-Silico Clinical Trials as a New Paradigm in Medicine

2020 9th Mediterranean Conference on Embedded Computing (MECO), 2020
In silico clinical trial represents a new paradigm for development of new drug and medical device. In SILICOFCM project Familial Cardiomyopathy disease was modelled with comprehensive list of patient specific features such as genetic, biological, pharmacologic, clinical, imaging.
openaire   +1 more source

Identifying the patient harms to include in an in silico clinical trial

Computer Methods and Programs in Biomedicine, 2023
Clinical trials represent a crucial step in the development and approval of medical devices. These trials involve evaluating the safety and efficacy of the device in a controlled setting with human subjects. However, traditional clinical trials can be expensive, time-consuming, and ethically challenging.
Philippe Favre, Jeff Bischoff
openaire   +2 more sources

In Silico Trial Approach for Biomedical Products: A Regulatory Perspective

Combinatorial Chemistry & High Throughput Screening, 2022
Abstract: The modern pharmaceutical industry is transitioning from traditional methods to advanced technologies like artificial intelligence. In the current scenario, continuous efforts are being made to incorporate computational modeling and simulation in drug discovery, development, design, and optimization.
Jobin Jose   +3 more
openaire   +2 more sources

Computational model of tumor growth for in silico trials

Medical Imaging 2021: Physics of Medical Imaging, 2021
Digital breast tomosynthesis (DBT) can improve the detectability of breast cancer by eliminating overlapping breast tissues that affects the performance of digital mammography (DM) systems. It is yet to be established if DBT can detect lesions at earlier progression stages than DM.
Aunnasha Sengupta   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy